Scalpel Weekly News

Week of: October 10, 2016

IN THE NEWS


First Automated Insulin Delivery Device for Type 1 Diabetes

On September 28, 2016 the FDA approved Medtronic’s MiniMed 670G hybrid closed looped system, the first FDA-approved device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses in people 14 years of age and older with type 1 diabetes. The MiniMed 670G hybrid closed looped system is manufactured by Medtronic, headquartered in Dublin, Ireland. Click title to continue reading...


 
MEDICAL ALERTS


Orthopedic Surgical Power Tool Adaptor May Explode

DePuy Synthes announced on September 28, 2016, that it is recalling the Adaptor and Light Adaptor for their SBD and SBD II due to a potential for the adaptors to produce extreme internal pressure, which may cause the device to explode. The use of affected products may cause serious adverse health consequences, including death. Click title to continue reading...



FDA Response, Developments, Approvals Concerning Mylan’s EpiPen Controversy

On September 21, 2016, before the Committee on Oversight and Government Reform of the U.S. House of Representatives, Dr. Douglas Throckmorton, Deputy Director of the Center for Drug Evaluation and Research (CDER) at the FDA appeared and discussed the FDA’s role in ensuring the safety, efficacy, and availability of pharmaceutical products, such as epinephrine auto-injectors and generic drugs. The following paraphrases his statement. Click title to continue reading...



37,000 Deadly Bloodstream Infections Related to Dialysis

The CDC announced on September 27, 2016, that it is teaming up with a broad coalition of kidney and dialysis organizations to reduce the number of bloodstream infections in dialysis patients. Each year, about 37,000 people get potentially deadly bloodstream infections related to their dialysis treatment. Click title to continue reading...


  CASE ALERTS


Malpractice Accrual Date Extends; Failure to Monitor Aneurysm

A man experienced a significant period of abdominal pain and diarrhea. His long-time primary care physician referred him to a gastroenterologist for evaluation. Tests conducted as a part of the gastroenterologist’s evaluation showed that the man had a small (3.7 cm maximal dimension) abdominal aortic aneurysm (AAA). The gastroenterologist advised the primary care physician of the results of his evaluation including his discovery of the AAA. Click title to continue reading...



Data Collected as Required by State in Patient Safety Evaluation Systems Not Privileged

A woman underwent laparoscopic surgery. Following the surgery she died. The woman’s estate sued the hospital and a number of medical care providers alleging that her death was the result of medical negligence. Click title to continue reading...



Plaintiff Must Show Expert Complied with Personal Injury Testimony 20% Rule

A woman sought medical care from a certified nurse midwife. The certified nurse midwife’s care not only failed to resolve her symptoms and discomfort, but caused her to suffer complications that landed her in the hospital, required her to undergo surgery, and caused ongoing kidney disease. Click title to continue reading...


FEATURE


Excluding Hearing Loss Expert

As a special feature for our Premium subscribers we have included this feature containing an illustrative Memorandum in Support of Plaintiffs' Motion in Limine to preclude the defendants' experts from testifying about new defenses and theories of causation, the rare ototoxic side effect of a drug used to treat the plaintiff’s meningitis resulting in a hearing loss, that were not disclosed prior to trial of the plaintiff’s malpractice action. Click title to continue reading...